D6STNFa microsatellite locus correlates with CTLp frequency in unrelated bone marrow donor-recipient pairs

Human Immunology

Volumn 59, Issue 5, 1998, Pages 295-301

  Moghaddam, Payman Hanifi ^a   Zwinderman, Ailko ^a   Kazemi, Marzieh ^a   Van Der Voort Maarschalk, Minke ^a   Ruigrok, Marieke ^a   Naipal, Albert ^a   Van Der Slik, Arno ^a   Oudshoorn, MacHteld ^a   Giphart, Marius J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HLA MATCHING; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE CULTURE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BONE MARROW TRANSPLANTATION; GENETIC MARKERS; GRAFT VS HOST DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; MICROSATELLITE REPEATS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031976843     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00022-6     Document Type: Article

References (30)

1. McGlave P, Beatty P, Ash R, Hows J. Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation results in 102 cases . Blood. 75:1990;1728-1732.
2. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringdén O, Rozman C. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood. 75:1990;2459-2464.
3. Marks DI, Cullis JO, Ward KN, Lacey S, Szydlo R, Hughes TP, Schwarer AP, Lutz E, Barrett AJ, Hows JM, Batchelor JR, Goldman JM. Allogenic bone marrow transplantation for chronic myeloid leukemia using sibling and volenteer unrelated donors A comparison of complications in the first 2 years . Ann Intern Med. 119:1993;207-214.
4. Dupont B, Braun DW, Yunis EJ, Carpenter CP. HLA-D by cellular typing. Terasaki PI. Histocompatibility testing. 1980;229-267 UCLA, Los Angeles.
5. Baxter-Lowe L, Eckels DD, Ash R, Casper J, Hunter JB, Gorski J. The predictive value of HLA-DR oligotyping for MLC responses. Transplantation. 53:1992;1325-1375.
6. Termijtelen A, Erlish HA, Braun LA, Verduijn W, Drabbels JJM, Schroeijers WEM, van Rood JJ, de Koster HS, Giphart MJ. Oligonucleotide typing is a perfect tool to identify antigens simulatory in the mixed lymphocyte culture. Hum Immunol. 31:1991;241-245.
7. Kaminski ER, Hows J, Goldman J, Batchelor R. Optimising a limiting dilution culture system for quantitating frequencies of alloreactive cytotoxic T lymphocyte precursors. Cell Immunol. 137:1991;88-95.
8. Kaminski ER, Howset J, Bridge J, Davey NJ, Brookes PA, Green JE, Goldman JM, Batchelor JR. Cytotoxic T lymphocyte precursor (CTLp) frequency analysis in unrelated bone marrow transplantation two case studies . Bone Marrow Transplantation. 8:1991;47-50.
9. Zhang L, Rinke de Wit TF, Li S, van Rood JJ, Claas FH. Subtypes of HLA-A1 defined on the basis of CTL precursor frequencies. Hum Immunol. 27:1990;80-89.
10. Kaminski ER, Hows J, Brookes P, Mackinnon S, Hughes T, Avakian O, Sharrock C, Goldman J, Batchelor JR. Alloreactive cytotoxic T-cell frequency analysis and HLA matching for bone marrow transplants from HLA matched unrelated donors. Transplant Proc. 21:1989;2976-2977.
11. Verduijn W, Doxiades IIN, Anholts J, Drabbels JJM, Naipal A, D'Amaro J, Persijn SS, Giphart MJ, Schreuder GMTh. Biotinylated DRB sequence specific oligonucleotides, comparisons to serological HLA-DR typing organ donors in Eurotransplant. Hum Immunol. 37:1993;59-67.
12. Zhang L, Li SG, Van de Kerckhove B, Termijtelen A, van Rood JJ, Claas FHJ. Analysis of cytotoxic T cell precursor frequencies against individual HLA-A and B alloantigens. J Immunol Methods. 121:1989;39-45.
13. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissete J, Weissenbach J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 380:1996;152-154.
14. Don RH, Wainwright BJ, Bakker K, Mattick JS. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acid Res. 19:1991;4008.
15. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing strategy for multiple locus haplotypes. Am J Hum Genet. 56:1995;799-810.
16. Hanifi Moghaddam P, De Knijf P, Roep BO, Van de Auwera B, Naipal A, Gorus F, Schuit F, Giphart MJ. The genetic structure of IDDM1 Two separate regions in the MHC contribute to susceptibility or protection . Diabetes. 47:1998;259-265.
17. Raymond M, Rousset F. Population genetics software for exact tests and ecumenicism. J Heredity. 86:1995;248-249.
18. Schipper RF, Schreuder GMT, D'Amaro J, Oudshoorn M. HLA gene and haplotype frequencies in Dutch blood donors. Tissue Antigen. 48:1996;562-574.
19. Madrigal JA, Scott I, Arguello R, Szydlo R, Little A, Goldman JM. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunological Reviews. 157:1997;153-166.
20. Tay GK, Witt CS, Christiansen FT, Charron D, Baker D, Herrmann R, Smith LK, Diepeveen D, Mallal S, McCluskey J. Matching for MHC haplotypes results in improved survival following unrelated bone marrow transplantation. Bone Marrow Transplant. 15:1995;381-385.
21. Hamada H, Seidman M, Howard BH, Gorman CM. Enhanced gene expression by the poly(dT-dG). poly(dC-dA) sequence. Moll Cell Biol. 4:1984;2622-2630.
22. Tae HJ, Luo X, Kim KH. Roles of CCAAT/enhancer-binding protein and its binding site on repression and derepression of acetyl-CoA carboxylase gene. J Biol Chem. 269:1994;10475-10484.
23. Gogos JA, Karayiorgou M. Sequence-specific and length-dependent interaction of C2H2 zinc fingers and (TA)n microsatellites. Hum Genet. 98:1996;616-619.
24. Pociot F, Molvig J, Wogensen L, Dalboge H, Baek L, Nerup J. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol. 33:1991;37-49.
25. Jacob CO, Lee SK, Strassmann G. Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol. 156:1996;3043-3050.
26. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells a possible link to insulin-dependent diabetes mellitus . Eur J Immunol. 23:1993;224-231.
27. Holler E, Kolb HJ, Moller A, Kempeni J, Liesenfeld S, Pechumer H, Lehmacher W, Ruckdeschel G, Gleixer B, Riedner C, Ledderose G, Brehm G, Mittermüller J, Willmanns W. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood. 75:1990;1011-1016.
28. Wall DA, Sheehan KC. The roles of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency. Transplantation. 57:1994;273-279.
29. Ochs LA, Blazar BR, Roy J, Rest EB, Weisdorf DJ. Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Transplant. 17:1996;1085-1092.
30. Oudshoorn M, Cornelissen JJ, Fibbe WE, de Graeff-Meeder ER, Lie JLWT, Schreuder GMTH, Sintnicolaas K, Willemze R, Vossen JMJJ, van Rood JJ. Problems and possible solutions in finding an unrelated bone marrow donor Results of consecutive search for 240 Dutch patients . Bone Marrow Transplantation. 20:1997;1011-1017.